Common Contracts

Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information has been omitted from this exhibit because it is both (i) not material and (ii) is the type that Sesen Bio, Inc. treats as private or confidential. Information that has...

License Agreement • May 9th, 2022 • Sesen Bio, Inc. • Pharmaceutical preparations

• Contract Type
  License Agreement
• Filed
  May 9th, 2022
• Company
  Sesen Bio, Inc.
• Industry
  Pharmaceutical preparations

WHEREAS, UNIVERSITY is owner of Patent Rights as defined below on a stabilized anti-EGP-2 scFv fragment termed 4D5MOC-B (“Invention”);

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. LICENSE AGREEMENT

License Agreement • September 21st, 2016 • Eleven Biotherapeutics, Inc. • Pharmaceutical preparations

• Contract Type
  License Agreement
• Filed
  September 21st, 2016
• Company
  Eleven Biotherapeutics, Inc.
• Industry
  Pharmaceutical preparations

WHEREAS, UNIVERSITY is owner of Patent Rights as defined below on a stabilized anti-EGP-2 scFv fragment termed 4D5MOC-B (“Invention”);